All In Biotech

Free tool

FAERS Monitor: Mucinex Dm

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021620 or its brand name (Mucinex Dm, Dextromethorphan Hydrobromide, Guaifenesin). Reports on generic versions are filed under their own applications.

Reports

7,254

Serious

1,813

25% of reports

Hospitalization

571

Death reported

92

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective988
  • dizziness861
  • diarrhoea636
  • accidental overdose542
  • nausea509
  • overdose389
  • product use in unapproved indication355
  • somnolence299
  • feeling abnormal288
  • headache287
  • vomiting286
  • dyspnoea278
  • fatigue276
  • insomnia268
  • cough222

Reports by year received

View as table
YearReports
20041
20052
20066
200721
200820
200977
2010138
2011126
2012110
2013140
2014123
2015202
2016608
2017774
2018733
2019658
2020491
2021239
2022458
2023650
2024737
2025591
2026349

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,905 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
accidental overdoseSignal54243.640.222,218
overdoseSignal3895.24.81,340
dizzinessSignal8615.04.72,823
somnolenceSignal2994.33.9763
product use in unapproved indicationSignal3554.23.8857
feeling abnormalSignal2883.53.1514
insomniaSignal2682.92.6340
diarrhoeaSignal6362.92.7790
coughSignal2222.32.0163
drug ineffectiveSignal9882.22.1667
nausea5091.91.7211
vomiting2861.81.696
dyspnoea2781.41.336
headache2871.31.224
fatigue2761.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.